Cann Global (DB:54A) - Stock Price, News & Analysis

54A Stock Overview

Cann Global Limited engages in the production and distribution of medicinal cannabis medications, natural foods, and cosmeceuticals in Australia and internationally. More details

54A fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	6/6
Dividends	0/6

Risk Analysis

Earnings have declined by 13% per year over past 5 years

Does not have a meaningful market cap (€8M)

Makes less than USD$1m in revenue (A$980K)

Highly volatile share price over the past 3 months

+ 1 more risk

Cann Global Limited Competitors

Biofrontera

XTRA:B8FK

€16.4m

SynBiotic

DUSE:SBX

€27.9m

Cantourage Group

XTRA:HIGH

€57.6m

Apontis Pharma

XTRA:APPH

€80.3m

Price History & Performance

Summary of all time highs, changes and price drops for Cann Global
Historical stock prices
Current Share Price	AU$0.013
52 Week High	AU$0.25
52 Week Low	AU$0.011
Beta	1.27
11 Month Change	-46.00%
3 Month Change	8.00%
1 Year Change	-86.50%
33 Year Change	-97.43%
5 Year Change	-89.20%
Change since IPO	-99.56%

Recent updates

Shareholder Returns

	54A	DE Pharmaceuticals	DE Market
7D	-3.6%	1.4%	0.8%
1Y	-86.5%	-18.4%	9.1%

Return vs Industry: 54A underperformed the German Pharmaceuticals industry which returned -28.2% over the past year.

Return vs Market: 54A underperformed the German Market which returned 5.9% over the past year.

Price Volatility

Is 54A's price volatile compared to industry and market?
54A volatility
54A Average Weekly Movement	35.3%
Pharmaceuticals Industry Average Movement	6.9%
Market Average Movement	4.8%
10% most volatile stocks in DE Market	10.8%
10% least volatile stocks in DE Market	2.4%

Stable Share Price: 54A's share price has been volatile over the past 3 months.

Volatility Over Time: 54A's weekly volatility has decreased from 192% to 35% over the past year, but is still higher than 75% of German stocks.

About the Company

Founded	Employees	CEO	Website
2007	n/a	Sholom Feldman	www.canngloballimited.com

Cann Global Limited operates in medicinal cannabis and hemp food industries in Australia and internationally. The company operates through Hemp and Medical Cannabis Products, and Mining Exploration and Evaluation segments. It grows and cultivates hemp and medical cannabis products; and provides plant-based food and skincare products.

Cann Global Limited Fundamentals Summary

How do Cann Global's earnings and revenue compare to its market cap?
54A fundamental statistics
Market cap	€5.23m
Earnings (TTM)	-€3.34m
Revenue (TTM)	€659.78k

7.9x

P/S Ratio

-1.6x

P/E Ratio

Is 54A overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
54A income statement (TTM)
Revenue	AU$980.09k
Cost of Revenue	AU$752.05k
Gross Profit	AU$228.03k
Other Expenses	AU$5.19m
Earnings	-AU$4.97m

Last Reported Earnings

Dec 31, 2021

Next Earnings Date

Mar 07, 2022

Earnings per share (EPS)	-0.019
Gross Margin	23.27%
Net Profit Margin	-506.61%
Debt/Equity Ratio	0.7%

How did 54A perform over the long term?

See historical performance and comparison

Cann Global DB:54A Stock Report